A study conducted by researchers at UT Southwestern’s Simmons Cancer Center has revealed that a combination of two specific drug varieties may offer an effective treatment for most kinds of lung cancer by blocking their use of the cytokine tumour necrosis factor (TNF) as an “escape route”.
Ook interessant voor je
Reageer